Spots Global Cancer Trial Database for The Impact of Oligo-Fucoidan in Cancer Cachexia and Sarcopenia
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: The Impact of Oligo-Fucoidan in Cancer Cachexia and Sarcopenia
Official Title: A Phase II Trial for Oligo-Fucoidan in Cancer Cachexia and Sarcopenia
Study ID: NCT05623852
Conditions
Interventions
Study Description
Brief Summary: Fucoidan also ameliorates tumour and chemotherapy-induced muscle atrophy and -related cachectic symptoms in vivo and in vitro. To evaluate the effect of fucoidan in cancer cachexia or sarcopenia in cancer patients.
Detailed Description: Cancer cachexia is characterized by anorexia, skeletal muscle atrophy, and systemic inflammation. Fucoidan extracted from brown algae exhibits anti-inflammatory and anticancer activities. In addition, fucoidan also ameliorates tumour and chemotherapy-induced muscle atrophy and -related cachectic symptoms in vivo and in vitro. To evaluate the effect of fucoidan in cancer cachexia or sarcopenia in cancer patients.
Keywords
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Asia University, Taichung, Please Select, Taiwan
Szu-Yuan Wu, Taipei, Please Select, Taiwan
Contact Details
Name: Szu-Yuan Wu
Affiliation: Asia University, Taiwan
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
